Today: 21 May 2026
Petrobras stock (PBR) slips as oil falls; Tupi hits 1 million bpd, fertilizer restart in focus
15 January 2026
1 min read

Petrobras stock (PBR) slips as oil falls; Tupi hits 1 million bpd, fertilizer restart in focus

Rio de Janeiro, Jan 15, 2026, 12:45 BRT — Regular session

Petrobras’ shares listed in the U.S. slipped Thursday, despite the Brazilian oil giant highlighting new operational progress at its key offshore fields.

Petróleo Brasileiro S.A. – Petrobras is heavily dependent on volume. Production from the pre-salt—deepwater reserves buried beneath a thick salt layer—has powered earnings and dividends lately, and traders react swiftly to any sign that this growth is slowing.

Petrobras is also pressing forward with another venture: fertilizers. The timeline for reviving its urea and ammonia plants in Brazil’s northeast has turned into a subtle yet telling sign of how far the company’s leadership is willing to extend beyond its core oil and gas operations.

Energy stocks pulled back as crude prices dropped from recent highs. Brent crude fell roughly 3.3% to $64.34 a barrel, according to Reuters data. In U.S. trading, Exxon slipped about 0.8%, Chevron declined near 0.8%, and TotalEnergies was down around 1.4%.

Petrobras’ ADRs (PBR) slipped roughly 1.1%, closing at $12.52.

CEO Magda Chambriard told Reuters this week that Petrobras has hit a production rate of one million barrels per day (bpd) at the offshore Tupi field since Friday, describing it as “the rescue of a symbol for Brazil.” She also noted Petrobras now operates two giant fields, Tupi and Buzios, each with the potential to exceed 1 million bpd. In 2025, the company connected 11 wells to production vessels at Tupi and is evaluating the addition of a floating production vessel there by 2031. Baird Maritime / Work Boat World

Petrobras is gearing up to restart fertilizer production after years offline. The company said the FAFEN-SE plant in Sergipe resumed ammonia output on Dec. 31, followed by urea production on Jan. 3. Meanwhile, urea production at the FAFEN-BA plant in Bahia is set to resume by month’s end. Together, these two plants cover about 12% of Brazil’s urea demand, Petrobras said.

Petrobras announced in a separate filing that its 2026 annual general meeting will take place on April 16. Details on the time, location, and format will be provided at a later date.

The company’s corporate calendar indicates that investors will receive the next solid update on cash flow and shareholder returns when Petrobras releases its full annual financial statements for 2025 on March 5. An investor and analyst call is scheduled for March 6 to discuss the results.

The road ahead isn’t smooth. Petrobras is still vulnerable to oil price volatility, and geopolitical shifts can easily overshadow any company gains. In Brazil, environmental and regulatory hurdles add to the challenge, notably in the Foz do Amazonas basin, where the oil regulator has paused drilling after a synthetic-fluid spill.

Traders are focused on whether Petrobras can keep up the 1 million bpd output at Tupi and meet the end-January deadline for Bahia’s fertilizer restart. The bigger milestone arrives March 5, when Petrobras releases its annual results and management fields questions on dividends, spending, and production goals.

Stock Market Today

  • Why Retain ADP Stock: Solid Growth and Strategic Expansion
    May 21, 2026, 3:14 PM EDT. Automatic Data Processing (ADP) shares rose 9.5% over the past month, outperforming the industry's 6.5% decline. The company expects fiscal 2026 earnings to increase 14.6% year-over-year, with continued growth projected for 2027. ADP's three-tier business strategy and cloud-based Human Capital Management (HCM) solutions boost its competitive edge. Recent acquisitions, such as WorkForce Software, enhance capabilities. Despite a liquidity ratio below the industry average, ADP's consistent dividend payments and share repurchases demonstrate commitment to shareholders. Risks include intense competition and rising talent costs affecting profitability and retention. ADP currently holds a Zacks Rank #3 (Hold), reflecting cautious optimism amid growth and market pressures.

Latest articles

Nebius Shares Surge 15% After $2.6 Billion AI Power Plan Announced

Nebius Shares Surge 15% After $2.6 Billion AI Power Plan Announced

21 May 2026
Nebius Group N.V. shares surged 15.6% to $221.72 after announcing a fuel cell power deal with Bloom Energy, securing up to 328 MW of on-site electricity capacity for its AI infrastructure. The agreement could cost Nebius up to $2.6 billion over 10 years. Bloom shares rose 12.2% on the news. Nebius's first-quarter revenue jumped to $399 million from $50.9 million a year earlier.
Sirius XM stock nears new highs as traders look at audio strategy

Sirius XM stock nears new highs as traders look at audio strategy

21 May 2026
Sirius XM shares rose 6.8% to $28.90 by 2:07 p.m. EDT Thursday, outpacing major U.S. indexes. The rally followed CFO Zac Coughlin’s investor conference appearance and news of a renewed multi-year NASCAR broadcast deal. First-quarter subscriber losses were smaller than expected, and revenue topped forecasts. Volume reached 4.8 million shares, with a market value near $9.8 billion.
KEEL Surges as Investors Back Keel’s AI Data Center Plans

KEEL Surges as Investors Back Keel’s AI Data Center Plans

21 May 2026
Keel Infrastructure shares jumped 7.1% to $4.53 Thursday, nearing a 52-week high, as investors bet on its pivot from crypto mining to AI-focused power infrastructure. Trading volume reached 22.31 million shares, below average. The company reported a wider net loss of $145.35 million for the March quarter on lower revenue and warned its transformation faces risks tied to permits, costs, and competition.
Opendoor Technologies stock slips today as mortgage applications surge and Treasuries stay stubborn
Previous Story

Opendoor Technologies stock slips today as mortgage applications surge and Treasuries stay stubborn

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Next Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Go toTop